Premature Ejaculation: Clinical Trials

10 trials for Premature Ejaculation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 10
Phase 22Completed 2

Follow Premature Ejaculation: new trials by email Literature Review of Premature Ejaculation trials Research Report on Premature Ejaculation

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Study to Investigate KH-001 in Healthy Males
KH-001 besylate, KH-001 besylate placebo - Healthy Male Volunteers
Phase 1CompletedKadence Bio822023-11-142026-10-09
Brain Networks Implicated in Lifelong Premature Ejaculation Patients
Transcranial Radom Noise Stimulation, Take Dapoxetine, Comparation EEG changes between Sham Group against tRNS and Dapoxetin participants - Premature Ejaculation, Sexual Dysfunction
Phase 1 / Phase 2CompletedMoises Domingo1282021-02-022023-04-12
Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males
Treatment 1, Treatment 2, Treatment 3 - Healthy
Phase 1CompletedCTC Bio, Inc.302014-01-012014-09-15
A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
Treatment sequence 2, Treatment sequence 1 - Ejaculation
Phase 1CompletedJanssen Research & Development, LLC242011-04-012014-10-07
Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044
dapoxetine - Premature Ejaculation
Phase 1 / Phase 2CompletedYuhan Corporation242011-02-012012-08-01
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
Intervention A, Intervention B - Premature Ejaculation
Phase 1CompletedPlethora Solutions Ltd302010-09-012016-08-10
A Safety and Tolerability Study of Administration of PSD502
Intervention A, Intervention B, Intervention C - Premature Ejaculation
Phase 1CompletedPlethora Solutions Ltd212009-12-012016-08-10
Proof of Mechanism in ELT
GSK958108, Placebo - Premature Ejaculation
Phase 1CompletedGlaxoSmithKline332008-11-262017-06-14
FTIH Study With GSK958108
GSK958108, Placebo - Premature Ejaculation
Phase 1CompletedGlaxoSmithKline212008-04-122017-08-01
A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.
GSK557296 - Obstetric Labour, Premature, Premature Ejaculation
Phase 1CompletedGlaxoSmithKline422007-10-012012-03-19

Narrower conditions

Premature Birth (1)  ·  Sexual Dysfunction, Physiological (1)

Broader conditions

Ejaculatory Dysfunction (10)  ·  Genital Diseases (10)  ·  Genital Diseases, Male (10)  ·  Male Urogenital Diseases (10)  ·  Mental Disorders (10)  ·  Sexual Dysfunctions, Psychological (10)  ·  Urogenital Diseases (10)  ·  Sexual Dysfunction, Physiological (9)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Obstetric Labor Complications (1)  ·  Obstetric Labor, Premature (1)  ·  Pregnancy Complications (1)

Interventions

Clomipramine (1)  ·  Sildenafil Citrate (1)  ·  dapoxetine (1)  ·  epelsiban (1)

Sponsors

GlaxoSmithKline (3)  ·  Plethora Solutions Ltd (2)  ·  CTC Bio, Inc. (1)  ·  Janssen Research & Development, LLC (1)  ·  Kadence Bio (1)  ·  Moises Domingo (1)  ·  Yuhan Corporation (1)

Countries

United Kingdom (3)  ·  South Korea (2)  ·  United States (2)  ·  Italy (1)  ·  Spain (1)

Top investigators

Alejandro Molina Cabeza, MD (1)  ·  Annelize Koch, Dr (1)  ·  Yun Hi Kang, M.D. (1)

NIH funding

2023 (1)